Pub. Date : 2006 Oct 15
PMID : 17027571
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome. | Rosiglitazone | C-reactive protein | Homo sapiens |
2 | On multivariate analysis, changes in ADMA, endothelin-1, and CRP were independent predictors of improved endothelial reactivity with rosiglitazone. | Rosiglitazone | C-reactive protein | Homo sapiens |
3 | In conclusion, we have, for the first time, demonstrated the independent associations between the improvement in flow-mediated dilation and reductions in ADMA, endothelin-1, and CRP after 8 weeks of treatment with rosiglitazone in nondiabetic patients with the metabolic syndrome. | Rosiglitazone | C-reactive protein | Homo sapiens |
4 | These findings suggest that decreases in ADMA, endothelin-1, and CRP may serve as possible mechanisms for the improvement in endothelial function conferred by rosiglitazone treatment. | Rosiglitazone | C-reactive protein | Homo sapiens |